[1]廖　强,王　娟.骨质疏松患者血清25(OH)D，骨膜素、铁蛋白水平及其与骨折发生的相关性分析[J].现代检验医学杂志,2021,36(05):138-142.[doi:10.3969/j.issn.1671-7414.2021.05.031]
　LIAO Qiang,WANG Juan.Serum Levels of 25(OH)D, Periostin and Ferritin in Patients with Osteoporosisand Their Correlation with Fracture[J].Journal of Modern Laboratory Medicine,2021,36(05):138-142.[doi:10.3969/j.issn.1671-7414.2021.05.031]
点击复制

骨质疏松患者血清25(OH)D，骨膜素、铁蛋白水平及其与骨折发生的相关性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第36卷
期数:
2021年05期
页码:
138-142
栏目:
检验与临床
出版日期:
2021-10-14

文章信息/Info

Title:
Serum Levels of 25(OH)D, Periostin and Ferritin in Patients with Osteoporosisand Their Correlation with Fracture
文章编号:
1671-7414（2021）05-138-05
作者:
廖　强;  王　娟
( 重庆市江津区中心医院，重庆 402260)
Author(s):
LIAO Qiang ;  WANG Juan
(the Central Hospital of Jiangjin District, Chongqing 402260,China)
关键词:
骨质疏松; 25-羟维生素D; 骨膜素; 铁蛋白; 骨折
分类号:
R681；R392.11
DOI:
10.3969/j.issn.1671-7414.2021.05.031
文献标志码:
A
摘要:
目的　探究骨质疏松患者血清25-羟维生素D[25(OH)D]，骨膜素、铁蛋白水平及其与骨折发生的相关性。方法　将2018年1月~2020年1月重庆市江津区中心医院收治的112例骨质疏松未骨折患者纳入骨质疏松组，同期收治的93例骨质疏松性骨折患者纳入骨质疏松性骨折组，另选同期体检健康者50例为对照组，比较三组血清25(OH)D，骨膜素、铁蛋白水平，采用spearman相关分析血清25(OH)D，骨膜素、铁蛋白水平与骨质疏松性骨折的相关性，采用Logistic回归分析骨质疏松性骨折的影响因素，采用受试者工作特征曲线（ROC）分析血清25(OH)D，骨膜素、铁蛋白水平对骨质疏松性骨折的预测价值。结果　骨质疏松性骨折组和骨质疏松组血清25(OH)D水平低于对照组，差异有统计学意义（Q=13.173，25.974，均P＜0.05）；骨质疏松性骨折组血清25(OH)D水平低于骨质疏松组，差异有统计学意义（均Q=16.497，P＜0.05）；骨质疏松性骨折组和骨质疏松组血清骨膜素、铁蛋白水平均高于对照组，差异有统计学意义（Q=23.520，20.182；15.753，10.880，均P＜0.05）；骨质疏松性骨折组血清骨膜素、铁蛋白水平高于骨质疏松组，差异有统计学意义（Q=10.302，12.037，均P＜0.05）；骨质疏松患者血清25(OH)D水平与骨折发生呈负相关（r=-0.569，P＜0.05）；骨质疏松患者血清骨膜素、铁蛋白水平与骨折发生呈正相关（r=0.437，0.490，均P＜0.05）；血清25(OH)D水平下降、血清骨膜素水平升高、血清铁蛋白水平升高是骨质疏松性骨折的危险因素（P＜0.05）；血清25(OH)D，骨膜素、铁蛋白水平联合预测骨质疏松性骨折的AUC为0.965，敏感度为90.30%，特异度为92.00%，准确度为91.20%。结论　血清25(OH)D水平下降及血清骨膜素和铁蛋白水平升高有助于骨质疏松性骨折风险的预测，临床应密切关注骨质疏松患者血清25(OH)D，骨膜素、铁蛋白水平，以降低骨质疏松性骨折发生率。
Abstract:
Objective　To analyze the serum levels of 25-hydroxyvitamin D [25(OH)D], periostin, ferritin levels in patients withosteoporosis and their correlation with fracture. Methods　112 osteoporosis patients, 93 osteoporotic fracture patients and 50healthy individuals in the Central Hospital of Jiangjin District, Chongqing from January 2018 to January 2020 were included, andseted as osteoporosis group, osteoporotic fracture group and control group, respectively. Serum 25(OH)D, periostin, and ferritinlevels were compared among three groups. Spearman correlation was used to analyze the correlation of serum 25(OH)D,periostein and ferritin levels with osteoporotic fracture; Logistic regression was used to analyze the influencing factors ofosteoporotic fracture, and receiver operating characteristic curve (ROC) was used to analyze the predictive value of serum25(OH)D, periostein and ferritin levels on osteoporotic fracture. Results　Serum 25(OH)D level among three groups was thelowest in osteoporotic fracture group, followed by osteoporosis group, and was the highest in control group, the difference werestatistically significant(Q=13.173, 25.974, 16.497, all P<0.05). Serum periostein and ferritin levels among three groups were thehighest in osteoporotic fracture group, followed by osteoporosis group, and were the lowest in control group, the difference werestatistically significant(Q=23.520, 20.182; 15.753, 10.880; 10.302, 12.437, all P<0.05). Serum 25(OH)D level of osteoporosispatients was negatively correlated with the occurrence of osteoporotic fracture (r=-0.569, P<0.05). Serum levels of periosteinand ferritin in osteoporosis patients were positively correlated with the occurrence of osteoporotic fractures (r=0.437, 0.490, allP<0.05). Decreased serum 25(OH)D level, elevated serum periostein level, and elevated serum ferritin level were risk factors forosteoporotic fracture (P<0.05). The AUC, sensitivity, specificity and accuracy of combined detection of 25(OH)D, periostein andferritin levels in the prediction of osteoporotic fractures were 0.965, 90.30, 92.00% and 91.20% respectively. Conclusion Decreased serum 25(OH)D level and elevated serum levels of periostein and ferritin can be used to predict the risk of osteoporoticfracture, moreover, it is of great significance to closely monitor serum 25(OH)D, periostein, and ferritin levels in patients withosteoporosis to reduce the incidence of osteoporotic fractures.

参考文献/References:

[1] ALEJANDRO P, CONSTANTINESCU F. A review ofosteoporosis in the older adult[J]. Rheumatic DiseaseClinics of North America,2018,44(3):437-451.
[2] EZZAT S, LOUKA M L, ZAKARIA Z M, et al.Autophagy in osteoporosis: Relation to oxidativestress[J]. Journal of Cellular Biochemistry, 2018, 4(5):552-554.
[3] 王亚军， 陈晓， 智信， 等． 阿仑膦酸盐对骨质疏松性骨折愈合影响的研究进展[J]. 中华创伤杂志,2020,36(1):63-67.WANG Yajun, CHEN Xiao, ZHI Xin，et al. Researchprogress in effect of alendronate on healing ofosteoporotic fracture [J]. Chinese Journal of Trauma,2020, 36(1):63-67.
[4] JAGER N, SCH?PE J, WAGENPFEIL S, et al.The impact of UV-dose, body surface area exposedand other factors on cutaneous vitamin D synthesismeasured as serum 25(OH)D concentration: systematicreview and meta-analysis[J]. Anticancer Research,2018, 38(2): 1165-1171.
[5] KUMAR P, SMITH T, RAEMAN R, et al. Periostinpromotes liver fibrogenesis by activating lysyl oxidasein hepatic stellate cells[J]. The Journal of BiologicalChemistry, 2018, 293(33): 12781-12792.
[6] DUNN C D, BODEN D J. Three commercialimmunoradiometric “kit” assays for serum ferritinevaluated[J]. Clinical Chemistry, 1981, 27(7): 1280-1283.
[7] 刘栋，孙永明，华俊，等．胸、腰椎骨质疏松性骨折患者椎体骨铁含量、血清铁蛋白与骨密度的相关性[J]．中华骨质疏松和骨矿盐疾病杂志，2017,10 (2):104-109．LIU Dong, SUN Yongming, HUA Jun, et al.Correlation among bone iron content,serum ferritin andbone mineral densityin patients with thoracolumbarfractures[J]. Chinese Journal of Osteoporosis and BoneMineral Research, 2017,10 (2): 104-109.
[8] 吴长达，许邦发，严良二，等．骨折患者血清25-羟基维生素D 和甲状旁腺素水平与骨密度的相关性[J]. 标记免疫分析与临床,2019,26(3):491-493, 519.WU Changda, XU Bangfa, YAN Lianger, et al.Correlation between levels of serum 25-hydroxyvitaminD and parathyroid hormone and bone mineral densityin patients with fracture [J]. Labeled Immunoassays andClinical Medicine, 2019,26 (3): 491-493,519
[9] 李江华，李新梅，陈磊，等．血清骨膜素水平与老年髋部骨折患者骨密度相关性研究[J]. 中国骨质疏松杂志,2020,26(1):59-63.LI Jianghua, LI Xinmei, CHEN Lei, et al. Correlationbetween serum periostin level and bone mineral densityin elderly patients with hip fractures[J]. Chinese Journalof Osteoporosis, 2020,26 (1): 59-63.
[10] 邱贵兴，裴福兴，胡侦明，等．中国骨质疏松性骨折诊疗指南- 骨质疏松性骨折诊断及治疗原则[J].黑龙江科学,2018,9(2):85-88,95.QIU Guixing, PEI Fuxing, HU Zhenming, et al. Guideto diagnosis and treatment of osteoporotic fracture inChina-osteoporotic fracture diagnosis and treatmentprinciples [J]. Heilongjiang Science, 2018, 9 (2): 85-88，95
[11] COMPSTON J. Glucocorticoid-induced osteoporosis:an update[J]. Endocrine, 2018,6(1):7-16.
[12] KHAN S R, WHITEMAN D C, KIMLIN M G, et al.Effect of solar ultraviolet radiation exposure on serum25(OH)D concentration: a pilot randomised controlledtrial[J]. Photochemical & Photobiological Sciences,2018, 17(5): 570-577.
[13] SUN Xiaomin, CAO Zhenbo, TANISAWA K, et al.Effects of chronic endurance exercise training on serum25(OH)D concentrations in elderly Japanese men[J].Medicine and Science in Sports and Exercise, 2018,50(5):788.
[14] PLAYFORD M P, DEY A K, ZIEROLD C, et al.Serum active 1,25(OH)(2)D, but not inactive 25(OH)D vitamin D levels are associated with cardiometabolicand cardiovascular disease risk in psoriasis[J].Atherosclerosis, 2019, 289(13): 44-50.
[15] LU Mengdi, HOLLIS B W, CAREY V J, et al.Determinants and measurement of neonatal vitaminD: overestimation of 25(OH)D in cord blood usingCLIA assay technology[J]. The Journal of ClinicalEndocrinology and Metabolism, 2020, 105(4):e1085-e1092.
[16] ALI N K. Evaluation of the main minerals inosteoporosis patients: Calcium, phosphorus, vitamin25 (OH) D and alkaline phosphatase as a casestudy(Article)[J]. Indian Journal of Public HealthResearch and Development, 2019, 10(6):583-587.
[17] 李豆豆, 周维维, 曹猛.Periostin 对骨质疏松大鼠牙槽骨缺损修复效果的影响[J]. 实用口腔医学杂志,2019,35(5):629-633.LI Doudou, ZHOU Weiwei, CAO Meng.The effect ofperiostin on alveolar bone defect repair in osteoporosisrats [J]. Journal of Practical Stomatology, 2019,35 (5):629-633.
[18] PEPE J, BONNET N, HERRMANN F R, et al.Interaction between LRP5 and periostin genepolymorphisms on serum periostin levels and corticalbone microstructure[J]. Osteoporosis International ，2018, 29(2): 339-346.
[19] 位艳伟, 柳达, 付平, 等. 血清铁蛋白与血清铁调素在老年原发性高血压合并骨质疏松中作用的研究[J]. 中国骨质疏松杂志,2018,24(1):87-90.WEI Yanwei, LIU Da, FU Ping, et al. The effect ofserum ferritin and serum hepcidin on senile patientswith essential hypertension and osteoporosis [J].Chinese Journal of Osteoporosis, 2018, 24 (1): 87-90.
[20] 程千, 刘起富, 金铭, 等. 绝经后女性铁蓄积与骨代谢及机体炎症反应的相关性研究[J]. 中国骨质疏松杂志,2019,25(5):649-655.CHENG Qian, LIU Qifu, JIN Ming, et al. Thecorrelation between iron excess and bone metabolismand inflammation in postmenopausal women [J].Chinese Journal of Osteoporosis, 2019,25 (5): 649-655
[21] 张文韬, 陈勋, 宋涛, 等. 血清铁过载与老年女性骨质疏松性骨折的相关性[J]. 海南医学, 2018, 29(24):3443-3445.ZHANG Wentao, CHEN Xun, SONG Tao, et al.Relationship between serum iron overload andosteoporotic fracture in elderly women [J]. HainanMedical Journal, 2018, 29 (24): 3443-3445.
[22] 张迪晖，黄泽鑫，罗斌．体检女性血清铁蛋白与骨密度的关系[J]. 中国医药导报,2018,15(25):75-78.ZHANG Dihui, HUANG Zexin, LUO Bin. Therelationship between serum ferritin and bone density offemale check-ups [J]. China Medical Herald, 2018, 15(25): 75-78．

相似文献/References:

[1]武敏,艾文婷,李小凤,等.补肾健骨胶囊对绝经后骨质疏松患者骨代谢相关指标的影响[J].现代检验医学杂志,2015,30(05):73.[doi:10.3969/j.issn.1671-7414.2015.05.022]
　WU min,AI Wen-ting,LI Xiao-feng,et al.Change of Bone Metabolism in Postmenopausal Osteoporosis Patients Treated with Bushenjiangu Capsule[J].Journal of Modern Laboratory Medicine,2015,30(05):73.[doi:10.3969/j.issn.1671-7414.2015.05.022]
[2]席向红,郭小龙,王志伟,等.银川地区中老年人25-羟维生素D检测结果分析[J].现代检验医学杂志,2017,32(01):144.[doi:10.3969/j.issn.1671-7414.2017.01.040]
　XI Xiang-hong,GUO Xiao-long,WANG Zhi-wei,et al.Analysis of Vitamin D Results of Partial Middle and Old People in Yinchuan[J].Journal of Modern Laboratory Medicine,2017,32(05):144.[doi:10.3969/j.issn.1671-7414.2017.01.040]
[3]周 萍,郭 璇,武 倩,等.西安地区更年期女性骨代谢指标预测骨质疏松效果评估[J].现代检验医学杂志,2017,32(02):149.[doi:10.3969/j.issn.1671-7414.2017.02.042]
　ZHOU Ping,GUO Xuan,WU Qian,et al.Evaluation of Boned Metabolism Quota in the Prediction of Osteoporosis of Climacteric Female in Xi'an Area[J].Journal of Modern Laboratory Medicine,2017,32(05):149.[doi:10.3969/j.issn.1671-7414.2017.02.042]

备注/Memo

备注/Memo:
作者简介：廖强（1976-），男，本科，副主任医师，研究方向：临床医学，E-mail:liaoqiang197620@163.com。
通讯作者：王娟（1979-），女，本科，主治医师，研究方向：临床医学，E-mail:wangj197900@163.com。
更新日期/Last Update: 1900-01-01